Navigation Links
Phase III Data Published for Once Monthly Dose of Risedronate to Treat Postmenopausal Osteoporosis
Date:1/14/2008

BRIDGEWATER, N.J. and CINCINNATI, Jan. 14 /PRNewswire-FirstCall/ -- Results from a Phase III clinical trial evaluating the efficacy and safety of risedronate 150 mg once monthly for the treatment of postmenopausal osteoporosis were published this month in the January issue of the peer- reviewed journal Bone. In the non-inferiority study comparing risedronate 150 mg once monthly to risedronate 5 mg daily, increases in lumbar spine bone mineral density (BMD) at one year were similar for patients taking either the monthly or daily dosing regimens. All patients were supplemented with calcium and vitamin D.

In the study, BMD was measured at the lumbar spine, total hip, femoral neck, and femoral trochanter. There were no statistically significant differences in BMD increases between the risedronate 150 mg once monthly and the 5 mg daily dose groups at 12 months at all sites. In the study, the tolerability and safety profiles also were generally similar for the monthly and daily dosing regimens of risedronate.

"Our goal is to provide patients with convenient dosing options for risedronate," said Nora Zorich, M.D., Ph.D., Vice President, Global R&D, P&G Pharmaceuticals. "If this dose regimen is approved, there will be a once monthly dose option available to patients seeking less frequent dosing of risedronate."

About the Study

The MERIT-OP (Monthly Evaluation of Risedronate Trial in Osteoporosis) study is a 2-year, randomized, double-blind, active-control (5 mg daily risedronate) clinical trial which evaluated 1,292 postmenopausal women between 50 and 88 years old, mean age 64.9, from 47 clinical centers in 13 countries. The participants had osteoporosis, defined as a lumbar spine (LS) BMD T-score less than -2.5 or a LS BMD T-score less than -2.0 and at least one prevalent vertebral fracture. Patients were randomized to dosing regimens of either risedronate 150 mg monthly or risedronate 5 mg daily and received daily supplements of calcium
'/>"/>

SOURCE Procter & Gamble
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Mass. , July 28, 2015  Today, Sekisui ... A compact, affordable and efficient instrument, with a broad ... bring significant benefits to the physicians, office or hospital ... of up to 580 tests/hour with ISE, 72 patient ... and has 36 onboard assays (+3 ISE) to meet ...
(Date:7/28/2015)... ROCHESTER, N.Y. , July 28, 2015 ... of clinical trial imaging solutions, today announced that it ... the 4:00 p.m. ET market close on Tuesday, August ... chief executive officer, and Jim Groff , chief ... to discuss the company,s financial results and provide a ...
(Date:7/28/2015)... -- Zipnosis, the first virtual care solution to empower health care ... branded virtual care service line, announced an agreement with ... currently in use. ... As health systems consider how ... of providing their own branded online care for common medical ...
Breaking Medicine Technology:Sekisui Diagnostics Announces Launch of SK500 Clinical Chemistry System for US Laboratories 2VirtualScopics, Inc. Schedules Second Quarter 2015 Financial Results Press Release, Conference Call And Webcast 2VirtualScopics, Inc. Schedules Second Quarter 2015 Financial Results Press Release, Conference Call And Webcast 3Zipnosis Announces Group Health to use Virtual Care Service Line 2Zipnosis Announces Group Health to use Virtual Care Service Line 3
... Express Scripts, Inc. (Nasdaq: ESRX ) announced ... operations of $290.4 million and $1,275.8 million, or $0.59 and ... detailed in Table 4 were $0.82 and $2.97 per diluted ... "Through our unwavering focus on innovation, service and ...
... 2012  Endo Pharmaceuticals Holdings (Nasdaq: ENDP ) today ... corporate overview at the Cowen & Co. 32nd Annual Heath ... ET.  The conference will be held at the Boston Marriott ... and audio archive of the presentation will be available on ...
Cached Medicine Technology:Express Scripts Reports Fourth Quarter Results 2Express Scripts Reports Fourth Quarter Results 3Express Scripts Reports Fourth Quarter Results 4Express Scripts Reports Fourth Quarter Results 5Express Scripts Reports Fourth Quarter Results 6Express Scripts Reports Fourth Quarter Results 7Express Scripts Reports Fourth Quarter Results 8Express Scripts Reports Fourth Quarter Results 9Express Scripts Reports Fourth Quarter Results 10Express Scripts Reports Fourth Quarter Results 11Express Scripts Reports Fourth Quarter Results 12
(Date:7/28/2015)... FAIRFAX, Virginia (PRWEB) , ... July 28, 2015 , ... ... in the Washington, D.C. technology community for over 20 years, has selected Lisa Dezzutti, ... for the upcoming year. , “I am excited to serve this organization that empowers ...
(Date:7/28/2015)... ... July 28, 2015 , ... Dr. Aziz Ahmad recently gave ... took place from noon to 1 p.m. Tuesday, June 23, at the Gulf Coast ... , Dr. Ahmad is board-certified in colorectal surgery and has more than 35 years ...
(Date:7/28/2015)... ... July 28, 2015 , ... OrthAlign, Inc., ... its ORTHALIGN PLUS® system, a palm-sized, single-use navigation device for Total Hip Arthroplasty ... precision with practicality in a revolutionary way for Total Knee Arthroplasty surgeries and ...
(Date:7/28/2015)... ... 28, 2015 , ... Healthpointe ’s Cosmetic Laser Institute in Anaheim is ... state, and reduces the appearance of fine lines and wrinkles. , According to the ... instantly add volume to your cheek area to correct age-related volume loss in adults ...
(Date:7/28/2015)... ... July 28, 2015 , ... BMI of Texas, which specializes in a variety ... weight loss surgery procedure. Committed to helping patients achieve their weight loss goals ... Texas is one of the first practices in South Texas to offer the ...
Breaking Medicine News(10 mins):Health News:Lisa Dezzutti Named President of Women in Technology (WIT) Board of Directors 2Health News:Dr. Aziz Ahmad Delivers Talk at Gulf Coast Medical Center 2Health News:OrthAlign, Inc. Announces U.S. Commercial Launch of ORTHALIGN PLUS®, the most complete handheld navigation device for use in Total Hip Arthroplasty Surgery 2Health News:OrthAlign, Inc. Announces U.S. Commercial Launch of ORTHALIGN PLUS®, the most complete handheld navigation device for use in Total Hip Arthroplasty Surgery 3Health News:Healthpointe’s Cosmetic Laser Institute Now Providing Juvéderm Voluma XC in Anaheim 2Health News:Healthpointe’s Cosmetic Laser Institute Now Providing Juvéderm Voluma XC in Anaheim 3Health News:BMI of Texas Now Offering Duodenal Switch Surgery – Weight Loss Procedure Helps Obese Patients Lose Weight Quickly 2Health News:BMI of Texas Now Offering Duodenal Switch Surgery – Weight Loss Procedure Helps Obese Patients Lose Weight Quickly 3
... Reporter , FRIDAY, May 4 (HealthDay News) -- Even youngsters who ... heart disease. Just ask Heather Link. When she was 12, ... several weeks after a dental checkup, she was suddenly engaged in ... as infective endocarditis, which develops when bacteria enter the bloodstream and ...
... are common among patients with chronic obstructive pulmonary disease ... associated with an increased mortality risk, according to a ... recruited from five pulmonary clinics in the United States ... lead author Miguel Divo, MD, a physician in the ...
... HealthDay Reporter , THURSDAY, May 3 (HealthDay News) -- ... regardless of how "full" a person may feel, the ... when tempted by yummy foods. The study on ... participants, and the authors acknowledge that their findings are ...
... , THURSDAY, May 3 (HealthDay News) -- The use of ... for infants, new research suggests. In combination with other ... for adults with HIV, the virus that causes AIDS. These ... researchers said. The study was conducted by the U.S. ...
... , THURSDAY, May 3 (HealthDay News) -- ... type of bleeding stroke should immediately be transferred to ... cases each year, according to new recommendations from the ... Aneurysmal subarachnoid hemorrhage occurs when a weakened blood vessel ...
... off from work email significantly reduces stress and allows employees ... UC Irvine and U.S. Army researchers. Heart rate monitors ... while software sensors detected how often they switched windows. People ... in a steady "high alert" state, with more constant heart ...
Cached Medicine News:Health News:A Heart Disease Veteran at Just Age 12 2Health News:A Heart Disease Veteran at Just Age 12 3Health News:Comorbidities increase risk of mortality in COPD patients 2Health News:Why You Overeat Even When You're Full 2Health News:Why You Overeat Even When You're Full 3Health News:HIV Drug Tenofovir Safe During Pregnancy, Study Suggests 2Health News:In Some Brain Bleeds, Patients Do Better at High-Volume Hospitals 2Health News:Email 'vacations' decrease stress, increase concentration, researchers say 2
Patient Monitor...
... The Flu A/B ASR contains primers and a ... A and an Alexa 532-labeled probe to detect ... and a Texas Redlabeled probe for a separate ... that can detect FAM, Alexa 532 and Texas ...
... The RSV ASR contains primers and a ... Respiratory Syncytial Virus (RSV). In addition, this ... probe for a,separate sample processing control. This ... FAM and Texas Red reporter dyes such ...
Digital Ultrasonic Diagnostic Imaging System...
Medicine Products: